James J Ashton
Overview
Explore the profile of James J Ashton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ashton J, Brooks-Warburton J, Allen P, Tham T, Hoque S, Kennedy N, et al.
Frontline Gastroenterol
. 2023 Apr;
14(3):258-262.
PMID: 37056322
No abstract available.
12.
Seaby E, Leggatt G, Cheng G, Thomas N, Ashton J, Stafford I, et al.
medRxiv
. 2023 Apr;
PMID: 37034701
The 100,000 Genomes Project (100KGP) diagnosed a quarter of recruited affected participants, but 26% of diagnoses were in genes not on the chosen gene panel(s); with many being variants of...
13.
Marino L, Paulson S, Ashton J, Weeks C, Young A, Pappachan J, et al.
Cardiol Young
. 2022 Nov;
33(10):1879-1888.
PMID: 36325968
Background: Growth failure in infants born with CHD is a persistent problem, even in those provided with adequate nutrition. Objective: To summarise the published data describing the change in urinary...
14.
Marino L, Paulson S, Ashton J, Weeks C, Young A, Pappachan J, et al.
Nutrients
. 2022 Oct;
14(19).
PMID: 36235609
Growth failure in infants born preterm is a significant issue, increasing the risk of poorer neurodevelopmental outcomes and metabolic syndrome later in life. During the first 1000 days of life...
15.
Ashton J, Cheng G, Stafford I, Kellermann M, Seaby E, Cummings J, et al.
Inflamm Bowel Dis
. 2022 Sep;
29(4):511-521.
PMID: 36161322
Background: Crohn's disease (CD) is highly heterogenous and may be complicated by stricturing behavior. Personalized prediction of stricturing will inform management. We aimed to create a stricturing risk stratification model...
16.
Ashton J, Seaby E, Beattie R, Ennis S
J Crohns Colitis
. 2022 Aug;
17(3):450-458.
PMID: 36006803
Studies of Crohn's disease have consistently implicated NOD2 as the most important gene in disease pathogenesis since first being identified in 2001. Thereafter, genome-wide association, next-generation sequencing and functional analyses...
17.
Mossotto E, Boberska J, Ashton J, Stafford I, Cheng G, Baker J, et al.
Sci Rep
. 2022 Aug;
12(1):14101.
PMID: 35982195
Crohn's disease (CD) is characterised by chronic inflammation. We aimed to identify a relationship between plasma inflammatory metabolomic signature and genomic data in CD using blood plasma metabolic profiles. Proton...
18.
Ashton J, Young A, Johnson M, Beattie R
Pediatr Res
. 2022 Jul;
93(2):324-333.
PMID: 35906306
The rise of machine learning in healthcare has significant implications for paediatrics. Long-term conditions with significant disease heterogeneity comprise large portions of the routine work performed by paediatricians. Improving outcomes...
19.
Bethell G, Ashton J, Adams S, Beattie R, Hall N, Stanton M
J Pediatr Gastroenterol Nutr
. 2022 Jun;
75(3):308-312.
PMID: 35666884
Objectives: To determine how the use of biological therapy is associated with surgical intervention for paediatric inflammatory bowel disease (PIBD) at a population level. Methods: Hospital Episode Statistics data were...
20.
Ashton J, Barakat F, Barnes C, Coelho T, Batra A, Afzal N, et al.
J Pediatr Gastroenterol Nutr
. 2022 Jun;
75(2):e20-e24.
PMID: 35666860
Objective: The incidence of paediatric inflammatory bowel disease (IBD) has been increasing over 25 years; however, contemporary trends are not established and the impact of COVID-19 on case rates is...